How is the Altimmune Inc today?

The Altimmune Inc today is trading in the down by -3.68% at 5.23.

What is Altimmune Inc Annual Revenue?

Altimmune Inc Annual Revenue fell 95.31%, in the last year to $0.02 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Altimmune Inc Annual Net Profit?

Altimmune Inc Annual Net Profit fell 7.48% in the last year to $95.06 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Altimmune Inc Price to Earning Ratio?

Altimmune Inc Price to Earning Ratio is -4.7, which is negative.

What is Altimmune Inc Stock Price?

Altimmune Inc Stock Price fell 30.36% and underperformed its sector by 69.98% in the past year.

What is Altimmune Inc Quarterly Net profit?

Altimmune Inc Quarterly Net profit rose 19.75% YoY to $19.58 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Altimmune Inc Debt to Equity Ratio?

Altimmune Inc Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Altimmune Inc Return on Equity(ROE)?

Altimmune Inc Return on Equity(ROE) for the last financial year was -59.86%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Altimmune Inc Mutual Fund Holding?

Altimmune Inc Mutual Fund Holding decreased by 6.84% in the last quarter to 31.38.

What is Altimmune Inc Promoter Share Holding?

Altimmune Inc Promoter Share Holding increased by 0.12% in the most recent quarter to 4.9%.

What is Altimmune Inc Interest Coverage Ratio?

Altimmune Inc Interest Coverage Ratio is -10561.11, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Altimmune Inc Institutional Holding?

Altimmune Inc Institutional Holding decreased by 2.94% in the last quarter to 49.79.

Altimmune Inc XNAS: ALT

Altimmune Inc Live Share Price Today, Share Analysis and Chart

Name: Altimmune Inc: Is Infosys Ltd. worth buying?
Item: Altimmune Inc
Rating: 1.15675
Author: Trendlyne DVM scores

about

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-bas...

5.23 -0.20 (-3.68%)

53.14% Fall from 52W High

1.5M XNAS Volume

XNAS 02 Jun, 2025 1:42 PM (EDT)

Board Meeting

The next board meeting for Altimmune Inc is on 04 Jun 2025 for the purpose of Jefferies Global Healthcare Conference See details

Not Eligible

-

Expensive Valuation

5.5 / 100

Technically Neutral

40.8 / 100

21

1Yr Price target upside is 293%

9 analysts

Altimmune Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Altimmune Inc FAQ

How is Altimmune Inc today?

Altimmune Inc today is trading in the red, and is down by -3.68% at 5.23.

How has Altimmune Inc performed historically?

Altimmune Inc is currently trading down -3.68% on an intraday basis. In the past week the stock fell -8.41%. stock has been down -21.35% in the past quarter and fell -30.36% in the past year. You can view this in the overview section.